Nuvation Bio Inc.NUVBNYSE
LOADING
|||
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | 5.42% |
| Q2 2025 | 11.22% |
| Q1 2025 | -16.03% |
| Q4 2024 | 5.65% |
| Q3 2024 | -93.90% |
| Q2 2024 | 3437.74% |
| Q1 2024 | -16.34% |
| Q4 2023 | -17.29% |
| Q3 2023 | -0.16% |
| Q2 2023 | -1.05% |
| Q1 2023 | 11.36% |
| Q4 2022 | -20.77% |
| Q3 2022 | -26.37% |
| Q2 2022 | 39.52% |
| Q1 2022 | -5.79% |
| Q4 2021 | 28.50% |
| Q3 2021 | 22.00% |
| Q2 2021 | -11.62% |
| Q1 2021 | 70.08% |
| Q4 2020 | 8.22% |
| Q3 2020 | 17.45% |
| Q2 2020 | 0.69% |
| Q1 2020 | -17.10% |
| Q4 2019 | 118.04% |
| Q3 2019 | -34.21% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |